These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17992769)
41. Psychotropic drug use in older people: a review. Greene JA J Tenn Med Assoc; 1985 Jul; 78(7):431-5. PubMed ID: 4033112 [No Abstract] [Full Text] [Related]
42. [The importance of psychotropic drugs for gerontology]. Krebs-Roubicek E; Pöldinger W Fortschr Med; 1990 Jan; 108(1):32-4, 37-8, 41. PubMed ID: 2179079 [TBL] [Abstract][Full Text] [Related]
44. [When the typical family doctor patient needs a psychotropic drug. The most important guidelines for therapy]. Laux G MMW Fortschr Med; 2006 Nov; 148(46):26. PubMed ID: 17615783 [No Abstract] [Full Text] [Related]
45. First Do No Harm: Psychotropic Prescribing Principles and Guidelines for Older Adults. Kverno K J Psychosoc Nurs Ment Health Serv; 2020 Aug; 58(8):12-16. PubMed ID: 32744642 [TBL] [Abstract][Full Text] [Related]
46. Medical treatment of psychiatric patients: possible polypharmacy problems. Norton JC; Ludwig AM Hosp Community Psychiatry; 1982 Apr; 33(4):305-7. PubMed ID: 7076147 [No Abstract] [Full Text] [Related]
47. Psychiatric drug therapy. Pitfalls and how to avoid them. Ostow M N Y State J Med; 1978 Jul; 78(8):1221-7. PubMed ID: 276658 [No Abstract] [Full Text] [Related]
48. Building a treatment safety net for children in child welfare programs. Bellonci C; Gleason MM J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):855-7. PubMed ID: 22917196 [No Abstract] [Full Text] [Related]
49. [Therapy with psychotropic drugs in child and adolescent psychiatry. Possibilities and limitations]. du Bois R Dtsch Krankenpflegez; 1990 Apr; 43(4):266-9. PubMed ID: 2116274 [No Abstract] [Full Text] [Related]
50. Drug interactions in psychopharmacology. Callahan AM; Fava M; Rosenbaum JF Psychiatr Clin North Am; 1993 Sep; 16(3):647-71. PubMed ID: 8415238 [TBL] [Abstract][Full Text] [Related]
51. [Reports. The psychopharmacological off-label prescribing in the treatment of children and adolescents with psychiatric disorders]. Oehler KU; Romanos M; Uzelli-Schwarz O; Dieffenbach R; Vulturius G; Holtmann M; Wewetzer C Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):315-7. PubMed ID: 27434690 [No Abstract] [Full Text] [Related]
52. Psychological considerations in the use of psychotropic drugs with women patients. Mogul KM Hosp Community Psychiatry; 1985 Oct; 36(10):1080-5. PubMed ID: 4054864 [TBL] [Abstract][Full Text] [Related]
53. [The family with reference to prescription of psychotropic drugs to the child and adolescent]. Dufour R Ann Med Psychol (Paris); 1993 Mar; 151(2):194-9. PubMed ID: 8285493 [No Abstract] [Full Text] [Related]
54. Risks and implications of interrupting maintenance psychotropic drug therapy. Baldessarini RJ Psychother Psychosom; 1995; 63(3-4):137-41. PubMed ID: 7624457 [No Abstract] [Full Text] [Related]
55. [Psychopharmaceuticals for children and adolescents are better than many seem to think]. Nissen G MMW Fortschr Med; 2005 Dec; 147(48):31; quiz 47-8. PubMed ID: 16389858 [No Abstract] [Full Text] [Related]
57. The use of psychotropic drugs in elderly patients with chronic mental illness. Howell T; Diamond RJ New Dir Ment Health Serv; 1986 Mar; (29):47-58. PubMed ID: 3702850 [No Abstract] [Full Text] [Related]
58. [Recent progress on drug therapy of mental diseases]. Ueshima K Seishin Shinkeigaku Zasshi; 1993; 95(9):671-81. PubMed ID: 7903465 [No Abstract] [Full Text] [Related]
59. [Letter: The prevention of the undesired physical adverse effects in the therapy with psychotropic drugs]. Müller-Oerlinghausen B Nervenarzt; 1976 Mar; 47(3):211. PubMed ID: 4742 [No Abstract] [Full Text] [Related]